# Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

> **NCT03844685** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 88 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Promensil
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03844685
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-05
- **Primary completion:** 2014-03-25
- **Final completion:** 2016-02-23
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2019-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844685, "Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03844685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*